Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D06HQM
|
|||
| Former ID |
DNCL003693
|
|||
| Drug Name |
Apo805K1
|
|||
| Indication | Psoriasis vulgaris [ICD-11: EA90; ICD-9: 696] | Phase 2 | [1] | |
| Company |
ApoPharma
|
|||
| Structure |
 |
Download2D MOL
|
||
| Formula |
C16H18KN3O5
|
|||
| Canonical SMILES |
[H+].C1=CC=C2C(=C1)C(=CN2)CC(C(=O)[O-])NC(=O)CCC(C(=O)[O-])N.[K+]
|
|||
| InChI |
1S/C16H19N3O5.K/c17-11(15(21)22)5-6-14(20)19-13(16(23)24)7-9-8-18-12-4-2-1-3-10(9)12;/h1-4,8,11,13,18H,5-7,17H2,(H,19,20)(H,21,22)(H,23,24);/q;+1/p-1/t11-,13-;/m1./s1
|
|||
| InChIKey |
JBUWHGCMOSDECA-LOCPCMAASA-M
|
|||
| CAS Number |
CAS 960155-19-5
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01483924) Study to Evaluate Apo805K1 in Subjects With Moderate to Severe Chronic Plaque Psoriasis. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.